Polycystic ovary syndrome in adolescence and early adulthood

Human Fertility

Volumn 3, Issue 2, 2000, Pages 96-100

  Michelmore, K F ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; DIANE; FOLLITROPIN; GONADORELIN; INSULIN; LUTEINIZING HORMONE; METFORMIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1;

ADOLESCENCE; AMENORRHEA AND OLIGOMENORRHEA; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE MARKER; EATING DISORDER; ENDOCRINE SYSTEM; FEMALE; GENETIC LINKAGE; HEALTH HAZARD; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; MASS SCREENING; OBESITY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PUBERTY;

EID: 0033862112     PISSN: 14647273     EISSN: None     Source Type: Journal    
DOI: 10.1080/1464727002000198771     Document Type: Conference Paper

References (48)

1. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
2. Menstrual irregularities are more common in adolescents with type 1 diabetes: Association with poor glycaemic control and weight gain
3. Pathogenesis of polycystic ovary syndrome - The enigma unravels?
4. Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients
5. A double-blind placebo-controlled glucose challenge in bulimia nervosa: Psychological effects
6. Standards for ovarian volume in childhood and puberty
7. Ovaries in sexual precocity
8. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women
9. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?
10. Insulin resistance and the polycystic ovary syndrome
11. Heterogeneity of the polycystic ovary syndrome: Clinical, endocrine and ultrasound features in 556 patients
12. Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin
13. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: A long-term follow-up focusing on natural history and circulating hormones
14. Vaginal adenosis and polycystic ovaries during infancy and childhood
15. Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents
16. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
17. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome
18. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus
19. Eating disorders
20. Studies of the epidemiology of bulimia nervosa
21. The eating disorder examination
22. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women
23. Polycystic ovary syndrome: A changing perspective
24. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism
25. Eating disorders
26. Bulimia nervosa and acne may be related: A case report
27. Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction
28. Relationship between the pubertal fall in sex hormone binding globulin and insulin-like growth factor binding protein-I. A synchronized approach to pubertal development?
29. Pubertal maturation of the internal genitalia: An ultrasound evaluation of 166 healthy girls
30. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome
31. Bulimia nervosa and polycystic ovary syndrome
32. A twin study of polycystic ovary syndrome and lipids
33. Repeated binge/purge cycles in bulimia nervosa: Role of glucose and insulin
34. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: Correlation with serum insulin and insulin-like growth factor-I
35. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome
36. Polycystic ovary syndrome and bulimia
37. Bulimia nervosa and polycystic ovary syndrome: Evidence for an occasional causal relationship
38. Polycystic ovaries and associated clinical and biochemical features in young women
39. Puberty and polycystic ovarian syndrome: The insulin/insulin-like growth factor I hypothesis
40. Hyperinsulinemia is common in family members of women with polycystic ovary syndrome
41. Polycystic ovaries - A common finding in normal women
42. Ovarian morphology and insulin sensitivity in women with bulimia nervosa
43. Precocious signs of polycystic ovaries in obese girls
44. Insulin-sensitising agents in polycystic ovary syndrome
45. Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome
46. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome
47. Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
48. Metabolism and endocrine secretion in response to a test meal in normal-weight bulimic women